Watch for Adbry, Cibinqo, and Rinvoq for Eczema

March 2022

You'll notice more meds for eczema trying to squeeze into the market...including Adbry, Cibinqo, and Rinvoq.

Adbry (tralokinumab) is an injectable "monoclonal antibody"...similar to Dupixent (dupilumab).

Cibinqo (abrocitinib) and Rinvoq (upadacitinib) are oral "Janus kinase (JAK) inhibitors."

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

New Generics Get Ready for the First Restasis Generics
Insulin Improve Safety With U-500 Insulin
Immunizations Expect More Use of Prevnar 20 or Vaxneuvance Pneumococcal Vaccines
Med Safety Double Down on Preventing Errors With "Two-for-One" Meds
Insomnia Put Mix-Ups With Melatonin to Rest
Mental Health Stay Alert for Suicide Warning Signs in Patients and Colleagues
Oral Health Listen for Dental Problems With Buccal or Sublingual Buprenorphine
Neurology & Pain Know How Meds for Diabetic Neuropathy Stack Up
Eczema Watch for Adbry, Cibinqo, and Rinvoq for Eczema